Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 3

Research Article

Effect of GutGard in the Management of Helicobacter pylori: A Randomized Double Blind Placebo Controlled Study

Table 3

Proportion of subjects turned from H. pylori—positive (Hp+) to negative (Hp) status as measured by HpSA and 13C-UBT.

GroupsDays HpSA  13C-UBT 
Hp+Hp (%)Hp+Hp (%)

GutGard 050500 (0)500 (0)
Placebo50500 (0)500 (0)
GutGard 3050500 (0)500 (0)
Placebo50500 (0)500 (0)
GutGard 60502228* (56)2624* (48)
Placebo50482 (4)491 (2)

: no. of subjects; Hp: H. pylori negative; Hp+: H. pylori positive.
%: percentage of subjects turned from Hp Positive to Hp Negative.
Significant difference compared to placebo.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.